PharmaShots | Incisive News in 3 Shots

Subscribe Now

COMBI-AD Study

Novartis Reports Results of Dual regimen in P-III COMBI-AD Study for Patients with Stage III Melanoma

Novartis Reports Results of Dual regimen in P-III COMBI-AD Study for Patients with Stage III Melanoma

September 17, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us